Form 4: Amgen Director Charles M. Holley Reports Acquisition of Common Stock

Director Charles M. Holley reports acquiring Amgen common stock through vested Restricted Stock Units (RSUs) and dividend equivalents.

Summary

• Charles M. Holley, a director at Amgen Inc., filed a Form 4 to report changes in beneficial ownership.
• On August 9, 2024, Holley acquired 131.787 shares of Amgen common stock at a price of $0.
• These shares were obtained through the vesting of Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Director Incentive Program.
• The vested RSUs are paid in shares of Amgen's common stock on a one-to-one basis and can be deferred by the director.
• Holley also indirectly owns 1,260 shares of Amgen common stock through the Holley Family Trust.
• The reported holdings include 983 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of stock acquisition by a director. It doesn't indicate any significant positive or negative development for the company.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.

Industry Context

Director share acquisitions are common and are viewed as a sign of confidence in the company's prospects. This filing is a routine disclosure required by the SEC.

Stakeholder Impact

• The acquisition of shares by a director may have a slightly positive impact on shareholder sentiment.

Key Dates